Share on StockTwits
 

Medgenics (NASDAQ:MDGN) Director Andrew Pearlman sold 25,000 shares of Medgenics stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $7.50, for a total value of $187,500.00. Following the transaction, the director now directly owns 40,562 shares of the company’s stock, valued at approximately $304,215. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Medgenics (NASDAQ:MDGN) traded down 4.78% on Friday, hitting $7.57. The stock had a trading volume of 141,965 shares. Medgenics has a 1-year low of $3.50 and a 1-year high of $8.01. The stock’s 50-day moving average is $6.52 and its 200-day moving average is $5.91. The company’s market cap is $139.4 million.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.